Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 42 of 42 entries
View as:

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

Phase: N/A Priority: Normal
NCT ID: NCT01942083 Org: User:
Start: 05/29/13 End: 07/11/16 Due: 07/11/17

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00706589 Org: User:
Start: 10/31/08 End: 04/30/10 Due: 04/30/11

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT03423680 Org: User:
Start: 02/22/18 End: 12/31/25 Due: 12/31/26

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00549952 Org: User:
Start: 10/31/07 End: 03/31/08 Due: 03/31/09

Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01197066 Org: User:
Start: 03/31/10 End: 11/30/16 Due: 11/30/17

Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02352285 Org: User:
Start: 12/31/12 End: 01/31/17 Due: 01/31/18

SWitching to Abilify Trial (SWAT)

Phase: N/A Priority: Normal
NCT ID: NCT00304616 Org: User:
Start: 10/31/04 End: 10/31/07 Due: 10/31/08

A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina

Phase: N/A Priority: Normal
NCT ID: NCT02087007 Org: User:
Start: 11/30/13 End: 07/31/15 Due: 07/31/16

ABF Tourette's Disorder Post Marketing Surveillance Study

Phase: N/A Priority: Normal
NCT ID: NCT01795105 Org: User:
Start: 06/30/12 End: 05/29/15 Due: 05/29/16

To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04150172 Org: User:
Start: 04/22/19 End: 05/10/19 Due: 05/10/20

To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04150146 Org: User:
Start: 07/05/19 End: 07/24/19 Due: 07/24/20

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Phase: N/A Priority: Normal
NCT ID: NCT06674291 Org: User:
Start: 11/30/24 End: 12/31/28 Due: 12/31/29

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Phase: N/A Priority: Normal
NCT ID: NCT03470233 Org: User:
Start: 05/25/17 End: 06/21/21 Due: 06/21/22

Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina

Phase: N/A Priority: Normal
NCT ID: NCT01444885 Org: User:
Start: 10/31/11 End: 07/31/12 Due: 07/31/13

Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness

Phase: N/A Priority: Normal
NCT ID: NCT00545675 Org: User:
Start: 12/31/07 End: 07/31/10 Due: 07/31/11

Iclusig PMS in CML or Ph+ALL Patients

Phase: N/A Priority: Normal
NCT ID: NCT03709017 Org: User:
Start: 08/07/18 End: 06/30/23 Due: 06/30/24

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

Phase: N/A Priority: Normal
NCT ID: NCT05048069 Org: User:
Start: 10/07/21 End: 12/15/24 Due: 12/15/25